22 July 2019

Four junior researchers, affiliated to the RIMLS, have each received a Veni grant of 250,000 Euro from the Netherlands Organization for Scientific Research (NWO). Our researchers received this prestigious grant for their remarkable and original talent and their ability to carry out innovative research.

They have only recently completed their doctorates and have now the challenging opportunity to develop their scientific ideas during the coming three years. The Veni grant from the NWO's Innovational Research Incentives Scheme is one of the most prestigious grants for young researchers, and to be awarded is considered an important step in an academic career. Although the Veni researchers are at the beginning of their careers, they have demonstrated to not only possess a remarkable talent in conducting academic research, but are also at the top of their scientific field internationally.

As RIMLS we can make the difference with these newly identified high potentials who can start their own research lines. Hopefully, they will also serve as role models for our current PhD's and motivate them to pursue a similar Veni track

During the application process our Veni applicants were supported by the RIMLS Grant Committee and the Department of Valorization. Their successful support is greatly appreciated and certainly contributed to this outstanding achievement.

On behalf of all RIMLS colleagues, we wish our laureates a lot of fun and excitement performing their studies and outlined plans in the years to come. Congratulations to all of you! 

RIMLS related awardees:

Rob Arts, theme Infectious diseases and global health
Project title: The role of the anti-inflammatory cytokines interleukin-37 and IL-38 for innate immune memory

Martijn van den Bosch, theme Inflammatory diseases
Project title: Alarmed monocytes with Janus-faced behavior as the driving force behind OA pathology

Jitske Jansen, theme Renal disorders
Project title: The REPAIR study: Regeneration of kidnEy ePitheliAl cells crossIng boRders

Annie Yang, theme Infectious diseases and global health
Project title: The secret lives of parasites in hepatocytes during malaria infection

Related news items


The Postdoctoral Networking Tour in artificial intelligence

2 July 2020

You are a postdoctoral researcher in the field of artificial intelligence? The Postdoc-NeT-AI offers you the opportunity to participate in one week of on-site visits to leading German universities, research institutes and companies. Apply now to this year's tour until 16 August 2020.

read more

Register for Phd courses via gROW What does this mean for you?

2 July 2020

From now on you can arrange everything related to the general RU PhD courses via gROW. Because of this there will be some changes in the registration! What does this mean for you?

read more

Experts on metabolic diseases still an unknown major problem...

1 July 2020

Six Dutch UMCs and a patient association contribute to treating and solving this major, often unknown, problem. Timely detection of metabolic diseases is vital. Therefore, Radboudumc is also part of the consortium “United for Metabolic Diseases”.

read more

Radboud Pluim for Lionne Ekers ambassador for the RIMLS institute

30 June 2020

Lionne Ekers received the Radboudpluim for her special merits for the Radboudumc. She is a born ambassador for our Institute.

read more

Stefan Listl member Lancet Commission on Oral Health

29 June 2020

In recognition of the global public health importance, woeful neglect of oral diseases, and the need for a broader understanding and commitment to global oral health within medicine and global health agendas, The Lancet recently established a Commission on Oral Health.

read more

Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection

29 June 2020

In a review in Cell Mihai Netea, Frank van de Veerdonk, Reinout van Crevel and Jorge Dominguez Andres propose that induction of trained immunity by whole-microorganism vaccines may represent an important tool for reducing susceptibility to and severity of SARS-CoV-2.

read more